Lexaria Bioscience CORP. (LEXX) — 8-K Filings

All 8-K filings from Lexaria Bioscience CORP.. Browse 24 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (24)

Lexaria Bioscience Files 8-K on Material Agreement & Equity Sales — Dec 16, 2025 Risk: medium
Lexaria Bioscience Corp. filed an 8-K on December 16, 2025, reporting on events that occurred on December 14, 2025. The filing indicates an entry into a materia
Lexaria Bioscience Files 8-K: Material Agreement, Equity Sales — Sep 29, 2025 Risk: medium
Lexaria Bioscience Corp. filed an 8-K on September 29, 2025, reporting on events as of September 26, 2025. The filing indicates an entry into a material definit
Lexaria Bioscience Terminates Material Agreement — Sep 25, 2025 Risk: medium
Lexaria Bioscience Corp. filed an 8-K on September 25, 2025, reporting the termination of a material definitive agreement as of September 19, 2025. The filing d
Lexaria Bioscience Corp. Signs Material Definitive Agreement — Jun 12, 2025 Risk: medium
Lexaria Bioscience Corp. entered into a material definitive agreement on May 14, 2025. The filing does not disclose specific details of the agreement, its count
Lexaria Bioscience Files 8-K on Material Agreement & Equity Sales — Apr 28, 2025 Risk: medium
Lexaria Bioscience Corp. filed an 8-K on April 28, 2025, reporting on events that occurred on April 24, 2025. The filing indicates an entry into a material defi
Lexaria Bioscience Corp. Files 8-K with Material Agreement — Feb 5, 2025 Risk: medium
On February 5, 2025, Lexaria Bioscience Corp. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and e
Lexaria Bioscience Corp. Files 8-K on Shareholder Vote Matters — Jan 15, 2025 Risk: low
Lexaria Bioscience Corp. filed an 8-K on January 15, 2025, reporting on a submission of matters to a vote of security holders. The filing details events that oc
Lexaria Bioscience Corp. Reports Director and Officer Changes — Jan 3, 2025 Risk: medium
Lexaria Bioscience Corp. filed an 8-K on January 3, 2025, reporting changes as of December 31, 2024. The filing covers the departure of directors, election of d
Lexaria Bioscience Corp. Files Material Definitive Agreement — Dec 18, 2024 Risk: medium
On December 16, 2024, Lexaria Bioscience Corp. entered into a material definitive agreement. The company, incorporated in Nevada with its principal executive of
Lexaria Bioscience Files 8-K on Shareholder Nominations — Oct 18, 2024 Risk: medium
Lexaria Bioscience Corp. filed an 8-K on October 18, 2024, reporting shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing date for this repo
Lexaria Bioscience Corp. Files 8-K with Material Agreement — Oct 16, 2024 Risk: medium
On October 14, 2024, Lexaria Bioscience Corp. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The com
Lexaria Bioscience Corp. Reports Director and Officer Changes — Oct 2, 2024 Risk: medium
Lexaria Bioscience Corp. filed an 8-K on October 2, 2024, reporting changes related to its board of directors and officers, as well as compensatory arrangements
Lexaria Bioscience Corp. Files 8-K: Board & Officer Changes — Sep 5, 2024 Risk: medium
Lexaria Bioscience Corp. filed an 8-K on August 31, 2024, reporting changes in its board of directors and executive officers, along with updates on compensatory
Lexaria Bioscience Corp. Signs Material Definitive Agreement — Aug 22, 2024 Risk: medium
Lexaria Bioscience Corp. announced on August 21, 2024, that it has entered into a material definitive agreement. The company, incorporated in Nevada, filed an 8
Lexaria Bioscience Corp. Files 8-K: Board Changes & Officer Compensation — Jul 17, 2024 Risk: medium
Lexaria Bioscience Corp. announced on July 15, 2024, a change in its board of directors, including the election of new directors and the appointment of certain
Lexaria Bioscience Files 8-K for Material Agreement & Equity Sales — Apr 30, 2024 Risk: medium
Lexaria Bioscience Corp. filed an 8-K on April 30, 2024, reporting the entry into a material definitive agreement and unregistered sales of equity securities. T
Lexaria Bioscience Corp. Files 8-K on Shareholder Vote Matters — Apr 24, 2024 Risk: medium
Lexaria Bioscience Corp. filed an 8-K on April 24, 2024, reporting on a submission of matters to a vote of security holders. The filing details information rela
Lexaria Bioscience Corp. Signs Material Definitive Agreement — Mar 21, 2024 Risk: medium
Lexaria Bioscience Corp. entered into a material definitive agreement on March 15, 2024. The filing does not disclose specific details of the agreement, such as
Lexaria Bioscience Appoints New CFO — Mar 15, 2024 Risk: medium
Lexaria Bioscience Corp. announced on March 14, 2024, the appointment of Mr. John D. Miller as Chief Financial Officer. Mr. Miller brings extensive financial le
Lexaria Bioscience Files 8-K — Mar 1, 2024 Risk: low
Lexaria Bioscience Corp. filed an 8-K on February 29, 2024, reporting other events. The filing details the company's incorporation in Nevada and provides its pr
Lexaria Bioscience Enters Material Agreement, Sells Equity — Feb 16, 2024 Risk: medium
Lexaria Bioscience Corp. entered into a material definitive agreement on February 14, 2024, involving the issuance of equity securities. The company, based in K
Lexaria Bioscience Confirms Nasdaq Listing for Common Stock & Warrants — Jan 30, 2024
Lexaria Bioscience Corp. filed an 8-K on January 29, 2024, to report 'Other Events.' This filing confirms the company's registration of its Common Stock and War
Lexaria Bioscience Confirms Nasdaq Listing for Stock & Warrants — Jan 24, 2024
Lexaria Bioscience Corp. filed an 8-K on January 24, 2024, primarily to disclose its common stock and warrants are registered on The Nasdaq Capital Market under
Lexaria Bioscience Files 8-K for Regulation FD Disclosure — Jan 4, 2024
Lexaria Bioscience Corp. filed an 8-K on January 4, 2024, primarily for Regulation FD Disclosure and to include Financial Statements and Exhibits. This filing i

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX